Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_ex32-1.htm |
| 10-K - 10-K - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_10k.htm |
| EX-31.2 - EXHIBIT 31..2 - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_ex31-1.htm |
| EX-22.1 - EXHIBIT 22.1 - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_ex22-1.htm |
| EX-21.1 - EXHIBIT 21.1 - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_ex21-1.htm |
| EX-4.2 - EXHIBIT 4.2 - CHEMBIO DIAGNOSTICS, INC. | brhc10021388_ex4-2.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Chembio Diagnostics, Inc.
Hauppauge, New York
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-3 (No. 333-227398 and No. 333-215813) and Forms S-8
(No. 333-151785 and No. 333-203633) of Chembio Diagnostics, Inc. of our report dated March 13, 2020, relating to the consolidated financial statements of Chembio Diagnostics, Inc which appears in this Annual Report on Form 10-K.
/s/ BDO USA, LLP
Melville, NY
March 11, 2021